日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Injectable chitosan-based hydrogel via in situ gelation modulates the inflammatory microenvironment and facilitates minimally invasive repair of peripheral nerve injury

注射型壳聚糖水凝胶通过原位凝胶化调节炎症微环境,并促进周围神经损伤的微创修复。

Zhai, Yunhao; Guan, Xiangheng; Lu, Caorui; Sun, Ruixuan; Qian, Yun; Li, Yi; Zhang, Kaihang; Wang, Xu; Xu, Linbin; Yin, Xinghao; Guo, Shang; Wu, Jinglei; Fan, Cunyi

Machine learning prediction of functional cure to pegylated interferon-alpha therapy in two HBV populations: Advantaged populations and HBeAg-negative patients

利用机器学习预测两种乙肝病毒感染人群(优势人群和HBeAg阴性患者)对聚乙二醇干扰素α疗法的功能性治愈情况

Li, Jiajie; Li, Huilin; Lin, Caorui; Jiang, Renquan; Wang, Longfei; He, Yujue; Yang, Xin; Gong, Kaitao; Xun, Zhen; Zheng, Qi

Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α

通过一种新型分阶段联合疗法(甘氨酸和干扰素-α)治疗性抑制HBsAg和HBV cccDNA

Lin, Caorui; Huang, Ying; Ran, Ning; Liu, Jie; Luo, Linjie; Zhang, Xin; Zheng, Xiaosang; Xun, Zhen; Xu, Siyi; Liu, Can; Kong, Xiaohong; Feng, Shiqing; Mao, Haiting; Ou, Qishui

A novel therapy targeting the gut-liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium

一种针对肠-肝轴治疗慢性乙型肝炎的新疗法:熊去氧胆酸联合双歧杆菌

Xun, Zhen; Yao, Xiaobao; Lin, Caorui; Yang, Xinyao; Zhang, Yanfang; Yang, Xin; He, Yujue; Jiang, Renquan; Lan, Yanping; Ye, Yuchen; Ye, Detai; Chen, Shanjian; Ma, Ke; Wu, Wennan; Xu, Siyi; Yang, Bin; Liu, Can; Chen, Jing; Zheng, Qi; Ou, Qishui

Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury

多组学揭示脱氧胆酸通过肠道微生物群调节胆汁酸代谢以拮抗四氯化碳引起的慢性肝损伤

Li Zhang, Zhiyi Zheng, Huanhuan Huang, Ya Fu, Tianbin Chen, Can Liu, Qiang Yi, Caorui Lin, Yongjun Zeng, Qishui Ou, Yongbin Zeng

Generalizable anchor aptamer strategy for loading nucleic acid therapeutics on exosomes

用于在外泌体上加载核酸治疗剂的通用锚定适体策略

Gang Han, Yao Zhang, Li Zhong, Biaobiao Wang, Shuai Qiu, Jun Song, Caorui Lin, Fangdi Zou, Jingqiao Wu, Huanan Yu, Chao Liang, Ke Wen, Yiqi Seow, HaiFang Yin

Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling

抑癌素M通过JAK-STAT信号诱导IFITM1表达抑制乙肝病毒复制

Yuchen Ye, Ya Fu, Caorui Lin, Ye Shen, Qingqing Yu, Xiaobao Yao, Qunfang Huang, Can Liu, Yongbin Zeng, Tianbin Chen, Songhang Wu, Zhen Xun, Qishui Ou

Effectiveness of SARS-CoV-2-inactivated vaccine and the correlation to neutralizing antibodies: A test-negative case-control study

SARS-CoV-2灭活疫苗的有效性及其与中和抗体的相关性:一项检测阴性病例对照研究

Liu, Can; Zhang, Jiawei; Zeng, Yongbin; Huang, Chun; Chen, Falin; Cao, Yingping; Wu, Siying; Wei, Donghong; Lin, Zhong; Zhang, Yali; Zhang, Ling; Teng, Jing; Li, Zishun; Hong, Guolin; Yang, Tianci; Ye, Huiming; Tu, Haijian; Xiao, Yupeng; Huang, Lishan; Lin, Caorui; Chen, Tianbin; Deng, Yanqin; Ou, Qishui; Li, Jinming

A novel TRIM22 gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis B

TRIM22 基因多态性通过细胞因子-细胞因子受体相互作用信号通路促进慢性乙型肝炎对 PegIFNα 治疗的反应

Long Wang #, Ni Lin #, Yanfang Zhang #, Shaoying Guo, Can Liu, Caorui Lin, Yongbin Zeng, Wennan Wu, Jianhui Guo, Chenggong Zhu, Fuguo Zhan, Qishui Ou, Zhen Xun

Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian

利用真病毒评估抗SARS-CoV-2抗体检测和中和反应的价值:福建疫情中10776名密切接触者的研究。

Zeng, Yongbin; Lin, Caorui; Liu, Can; Huang, Chun; Chen, Falin; Cao, Yingping; Wu, Siying; Wei, Donghong; Lin, Zhong; Zhang, Yali; Zhang, Ling; Teng, Jing; Li, Zishun; Hong, Guolin; Yang, Tianci; Ye, Huiming; Tu, Haijian; Xiao, Yupeng; Huang, Lishan; Zhang, Jiawei; Chen, Tianbin; Li, Jinming; Ji, Fusui; Ou, Qishui